Examine the data and tweets to deduce if the closing price of $gild will boost or lower at 2017-02-16. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-02,0.5,0.8,-0.7,-0.8,-0.8,-0.3,-1.0,-0.6,0.6,0.8,1.0
2017-02-03,0.6,0.6,-0.8,0.1,0.1,-0.1,-0.9,-0.8,0.2,0.6,0.8
2017-02-06,-0.5,0.4,-1.3,0.1,0.1,0.1,-0.8,-0.9,-0.1,0.6,0.7
2017-02-07,-0.8,0.2,-1.0,1.0,1.0,-0.7,-1.4,-1.8,-1.3,-0.3,-0.4
2017-02-08,0.7,0.7,-1.6,-8.6,-8.6,6.8,7.2,6.9,7.4,8.6,8.7
2017-02-09,1.1,1.8,-0.3,-1.9,-1.9,6.8,8.3,8.3,8.8,10.0,10.3
2017-02-10,-0.8,0.6,-1.4,1.2,1.2,3.8,6.3,6.6,7.0,8.1,8.7
2017-02-13,-1.2,0.2,-1.7,1.9,1.9,0.4,3.7,4.3,4.6,5.6,6.4
2017-02-14,1.6,1.7,-0.3,-0.1,-0.1,-1.1,3.2,4.1,4.4,5.3,6.4
2017-02-15,-3.0,0.3,-3.1,3.3,3.3,-3.5,-0.6,0.6,0.9,1.6,2.7

2017-02-02: rt AT_USER AT_USER updated large cap biotech cash $ibb $celg $gild $amgn $biib $regn |$gild reports earnings feb 7 and:|gilead sciences, inc. $gild shares sold by checchi capital advisers llc |gilead 
2017-02-03: rt AT_USER maybe eyeing $gild report, two nash plays w/ unusual options today, $ljpc buyers 2k feb $15 puts and $icpt opening sales f¡­|rt AT_USER why you're right to invest in gilead sciences stock $
2017-02-06: #gileadsciences priced like an automaker, sputtering gilead shares lure value bets. read more:  $gild|#gileadsciences priced like an automaker, sputtering gilead shares lure value bets. read more:  $g
2017-02-07: $gild when this 69 breaks it could get ugly.|management at $gild has clown dress on at this point. their inaction says a lot about their ability to know the ind¡­ |#gileadsciences inc. bottom line fal
2017-02-08: rt AT_USER $gild buybacks: "a more efficient way to destroy value than making an expensive acquisition, w. none of the upside." |#gileadsciences gilead stock dives to 22-month low as hep c cure drains
2017-02-09: #gileadsciences: #deadmoney? i'm long $gild long-term  via AT_USER|investors buy shares of gilead sciences, inc. $gild on weakness following analyst downgrade |AT_USER AT_USER AT_USER AT_USER hopefull
2017-02-10: rx reading: $gild quiet on m&amp;a, bayer and $jnj notch win for xarelto, $shpg faces pay-for-delay charges | jbp student made more than $50k read his review to find out how! $amd $xom $gild $feye|AT_
2017-02-11: yes, $gild|#biotechs eye retroviruses &amp; opportunistic infections conference #hiv $gsk $gild $btk AT_USER AT_USER |$gild hcv franchise is just gonna be flat in 2017 - without china.|rt AT_USER AT_U
2017-02-12: if $ibb can start moving, $gild $bmy (beaten names, which have offered fake bounce in the last few months )are on radar|rt AT_USER pharma m&amp;a in 2017: the most likely deal hunters  $amgn $gild $mr
2017-02-13: $gild #gilead sciences, inc. gilead presents new phase 2 data on bictegravir, an...  #news |$gild ph 2 trial in hiv with bictegravir - 97% patients had undetectable levels at 24 and 48 weeks. (1/2)|rt
2017-02-14: rt AT_USER isn't it odd that the company that cured hep c painlessly and continues to make hiv a chronic condition is the worst at pr¡­|rt AT_USER isn't it odd that the company that cured hep c painle
2017-02-15: rt AT_USER $gild well into the gap, 21d ahead. finally getting some love |$gild well into the gap, 21d ahead. finally getting some love |AT_USER you are not too late for the $gild bullet train express
Answer:
Examine the data and tweets to deduce if the closing price of $gild will boost or lower at 2017-02-16. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-02,0.5,0.8,-0.7,-0.8,-0.8,-0.3,-1.0,-0.6,0.6,0.8,1.0
2017-02-03,0.6,0.6,-0.8,0.1,0.1,-0.1,-0.9,-0.8,0.2,0.6,0.8
2017-02-06,-0.5,0.4,-1.3,0.1,0.1,0.1,-0.8,-0.9,-0.1,0.6,0.7
2017-02-07,-0.8,0.2,-1.0,1.0,1.0,-0.7,-1.4,-1.8,-1.3,-0.3,-0.4
2017-02-08,0.7,0.7,-1.6,-8.6,-8.6,6.8,7.2,6.9,7.4,8.6,8.7
2017-02-09,1.1,1.8,-0.3,-1.9,-1.9,6.8,8.3,8.3,8.8,10.0,10.3
2017-02-10,-0.8,0.6,-1.4,1.2,1.2,3.8,6.3,6.6,7.0,8.1,8.7
2017-02-13,-1.2,0.2,-1.7,1.9,1.9,0.4,3.7,4.3,4.6,5.6,6.4
2017-02-14,1.6,1.7,-0.3,-0.1,-0.1,-1.1,3.2,4.1,4.4,5.3,6.4
2017-02-15,-3.0,0.3,-3.1,3.3,3.3,-3.5,-0.6,0.6,0.9,1.6,2.7

2017-02-02: rt AT_USER AT_USER updated large cap biotech cash $ibb $celg $gild $amgn $biib $regn |$gild reports earnings feb 7 and:|gilead sciences, inc. $gild shares sold by checchi capital advisers llc |gilead 
2017-02-03: rt AT_USER maybe eyeing $gild report, two nash plays w/ unusual options today, $ljpc buyers 2k feb $15 puts and $icpt opening sales f¡­|rt AT_USER why you're right to invest in gilead sciences stock $
2017-02-06: #gileadsciences priced like an automaker, sputtering gilead shares lure value bets. read more:  $gild|#gileadsciences priced like an automaker, sputtering gilead shares lure value bets. read more:  $g
2017-02-07: $gild when this 69 breaks it could get ugly.|management at $gild has clown dress on at this point. their inaction says a lot about their ability to know the ind¡­ |#gileadsciences inc. bottom line fal
2017-02-08: rt AT_USER $gild buybacks: "a more efficient way to destroy value than making an expensive acquisition, w. none of the upside." |#gileadsciences gilead stock dives to 22-month low as hep c cure drains
2017-02-09: #gileadsciences: #deadmoney? i'm long $gild long-term  via AT_USER|investors buy shares of gilead sciences, inc. $gild on weakness following analyst downgrade |AT_USER AT_USER AT_USER AT_USER hopefull
2017-02-10: rx reading: $gild quiet on m&amp;a, bayer and $jnj notch win for xarelto, $shpg faces pay-for-delay charges | jbp student made more than $50k read his review to find out how! $amd $xom $gild $feye|AT_
2017-02-11: yes, $gild|#biotechs eye retroviruses &amp; opportunistic infections conference #hiv $gsk $gild $btk AT_USER AT_USER |$gild hcv franchise is just gonna be flat in 2017 - without china.|rt AT_USER AT_U
2017-02-12: if $ibb can start moving, $gild $bmy (beaten names, which have offered fake bounce in the last few months )are on radar|rt AT_USER pharma m&amp;a in 2017: the most likely deal hunters  $amgn $gild $mr
2017-02-13: $gild #gilead sciences, inc. gilead presents new phase 2 data on bictegravir, an...  #news |$gild ph 2 trial in hiv with bictegravir - 97% patients had undetectable levels at 24 and 48 weeks. (1/2)|rt
2017-02-14: rt AT_USER isn't it odd that the company that cured hep c painlessly and continues to make hiv a chronic condition is the worst at pr¡­|rt AT_USER isn't it odd that the company that cured hep c painle
2017-02-15: rt AT_USER $gild well into the gap, 21d ahead. finally getting some love |$gild well into the gap, 21d ahead. finally getting some love |AT_USER you are not too late for the $gild bullet train express
Answer:+Rise